R
RPRX
Royalty Pharma plc Class A Ordinary Shares
$58.99
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Royalty Pharma plc Class A Ordinary Shares in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
$1.74
Yield
2.96%
EPS
$1.46
P/E
41.2
Data as of Oct 1
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Expected EPS: $1.21
Nov 4
About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma buys the right to a share of the sales of medicines made by other drug companies and research institutions. It does not make drugs itself. When those medicines sell, Royalty Pharma collects a slice of the revenue, and it also funds new drug development in exchange for future royalties. It pays part of that income to shareholders as a dividend.